At A Glance
1
Enzolytics, Inc., a drug development company, focuses to the commercialization of its proprietary proteins for the treatment of debilitating infectious diseases.
2
No significant events in the past 90 days.
—
Market Cap
—
Revenue
—
Net Income
Employees1
Fundamentals
How The Business Makes Money
Enzolytics, Inc., a drug development company, focuses to the commercialization of its proprietary proteins for the treatment of debilitating infectious diseases. Its patented anti-HIV therapeutics and a proprietary methodology for producing human IgG1 monoclonal antibodies for treating infectious diseases with non-toxic passive immunotherapy. The company has clinically tested anti-HIV therapeutics. In addition, it has created a proprietary cell line that produces human monoclonal antibodies that target and neutralizes the HIV virus. Enzolytics Inc. is based in Plano, Texas.
Industry Biotechnology
Activity
What Changed Recently
No significant events in the past 90 days.
Company Profile
CIK0001421851
ISINUS2941121079
CUSIP294112107
Phone972 292 9414
Address2000 North Central Expressway, Plano, TX, 75074, US
SEC EDGAR